Home Newsfeeds New Street Research Initiates Coverage On Netflix with Neutral Rating, Announces Price Target of $304

New Street Research Initiates Coverage On Netflix with Neutral Rating, Announces Price Target of $304

New Street Research analyst Dan Salmon initiates coverage on Netflix (NASDAQ:NFLX) with a Neutral rating and announces Price Target of $304.

byBenzinga Newsdesk

January 4, 2023

1 minute read

New Street Research analyst Dan Salmon initiates coverage on Netflix (NASDAQ:NFLX) with a Neutral rating and announces Price Target of $304.

Game On In Israel! Playtika’s Bold Move Seals $300M Deal To Takeover Mobile Gaming Firm Innplay Labs

By Nabaparna Bhattacharya

Today, 10:55 AM

Playtika Holding Corp. (NASDAQ: PLTK) inked a pact to acquire Innplay Labs,

PLTK

Watsco Rewards Shareholders With Regular Quarterly Cash Dividend

By Shivani Kumaresan

January 3, 9:39 AM

Watsco Inc (NYSE:WSO) Board of Directors has declared a quarterly cash dividend of $2.45 per share. As announced in October,…

WSO

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

December 18, 2:05 PM

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.

ADD

Senseonics Announces The Last Patient Completion Of The 365-Day ENHANCE Pivotal Clinical Study

By Benzinga Newsdesk

September 26, 8:08 AM

Study Data to Support FDA Submission for the first 365-day Continuous Glucose Monitoring SystemSenseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of

SENS

New Street Research Initiates Coverage On Netflix with Neutral Rating, Announces Price Target of $304

Related Posts

Game On In Israel! Playtika’s Bold Move Seals $300M Deal To Takeover Mobile Gaming Firm Innplay Labs

Watsco Rewards Shareholders With Regular Quarterly Cash Dividend

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Senseonics Announces The Last Patient Completion Of The 365-Day ENHANCE Pivotal Clinical Study